Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lirussi

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
British Journal of Pharmacology|February 9, 2010
SAR150640, a selective beta3-adrenoceptor agonist, prevents human myometrial remodelling and activation of matrix metalloproteinase in an in vitro model of chorioamnionitisF Lirussi, M O'Brien, M Wendremaire, et al.
European Journal of Gastroenterology & Hepatology|February 7, 2001
Gallstone disease in an elderly population: the Silea studyF Lirussi, G Nassuato, D Passera, et al.
Liver|October 26, 1999
Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver diseaseF Lirussi, A Beccarello, L Bortolato, et al.
Pharmacological Research Communications|April 1, 1983
Effect of Silybin on biliary lipid composition in ratsG Nassuato, R M Iemmolo, F Lirussi, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1984
Oral and intravenous pharmacokinetics of ranitidine in patients with liver cirrhosisL Okolicsanyi, M Venuti, M Strazzabosco, et al.
Journal of Hepatology|May 1, 1991
Effect of Silibinin on biliary lipid composition. Experimental and clinical studyG Nassuato, R M Iemmolo, M Strazzabosco, et al.
Alimentary Pharmacology & Therapeutics|January 20, 1999
The monoethylglycinexylidide test for grading of liver cirrhosisL Fabris, R M Jemmolo, G Toffolo, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2004
Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver diseaseF Angelico, M Del Ben, R Conti, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
British Journal of Pharmacology|February 9, 2010
SAR150640, a selective beta3-adrenoceptor agonist, prevents human myometrial remodelling and activation of matrix metalloproteinase in an in vitro model of chorioamnionitisF Lirussi, M O'Brien, M Wendremaire, et al.
European Journal of Gastroenterology & Hepatology|February 7, 2001
Gallstone disease in an elderly population: the Silea studyF Lirussi, G Nassuato, D Passera, et al.
Liver|October 26, 1999
Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver diseaseF Lirussi, A Beccarello, L Bortolato, et al.
Pharmacological Research Communications|April 1, 1983
Effect of Silybin on biliary lipid composition in ratsG Nassuato, R M Iemmolo, F Lirussi, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1984
Oral and intravenous pharmacokinetics of ranitidine in patients with liver cirrhosisL Okolicsanyi, M Venuti, M Strazzabosco, et al.
Journal of Hepatology|May 1, 1991
Effect of Silibinin on biliary lipid composition. Experimental and clinical studyG Nassuato, R M Iemmolo, M Strazzabosco, et al.
Alimentary Pharmacology & Therapeutics|January 20, 1999
The monoethylglycinexylidide test for grading of liver cirrhosisL Fabris, R M Jemmolo, G Toffolo, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2004
Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver diseaseF Angelico, M Del Ben, R Conti, et al.
Pageof 5